Executive Summary
These 29 significant contract modifications totaling $3,864,631,168 in obligations over April 23, 2026, are overwhelmingly civilian-focused (28/29 non-defense, with only DLA Troop Support's $65M HHS award for DoD pharmaceuticals qualifying as defense-related), highlighting steady but fragmented spending across HHS ($452M+), VA ($1.7B+ dominated by Dell), Interior ($544M+), and NASA.
Dominant themes include healthcare services, construction/infrastructure, and IT/professional support, with no clear defense acceleration. Highest-conviction bullish signal is Dell Federal Systems L.P.'s $1.59B VA award, signaling massive tech exposure in veteran services. Key risk is execution on fixed-price contracts like Johnson Controls Government Systems LLC's $75.7M DOE ESPC ($0 outlayed, high risk over 25 years) and Whiting-Turner Contracting Company's $74.5M DHS build ($0 outlayed). Watch outlay progress on top awards amid potential CR uncertainty for future mods.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from April 22, 2026.
Investment Signals (7)
- Dell Federal Systems L.P. Secures $1.59B VA Contract Modification (HIGH)▲
Dell Federal Systems L.P. was awarded a $1,590,136,261 modification from Department of Veterans Affairs, the largest in this batch and a high-materiality bullish signal for tech in veteran services.
- Booz Allen Hamilton Inc. Lands $244.96M Interior IT Delivery Order (HIGH)▲
Booz Allen Hamilton Inc. received $244,961,186 total obligation (46% or $112.8M outlayed) from Department of Interior for computer systems design services (NAICS 541512), affirming capabilities via full/open competition.
- Emergent BioDefense Operations Lansing LLC Wins $211.4M HHS Biodefense R&D (HIGH)▲
Emergent BioDefense Operations Lansing LLC secured $211,409,788 (potential $647.5M options, $173.9M outlayed) sole-source firm-fixed-price from HHS BARDA for smallpox antiviral biotech R&D (NAICS 541714).
- S.J. Amoroso Construction Co. LLC Gains $69.5M VA Boiler Plant Build (MEDIUM)▲
S.J. Amoroso Construction Co., LLC awarded $69,517,876 firm-fixed-price from VA for new boiler plant at West Los Angeles Medical Center via full/open competition (NAICS 236220).
- Maximus Federal Services Inc. Advances $71.2M HHS CDC Contact Center (MEDIUM)▲
Maximus Federal Services, Inc. has $71,229,539 obligated ($46.5M outlayed, potential $91.5M) from HHS CDC for telemarketing services (NAICS 561422) through 2026.
- L3Harris Technologies Inc. Extends $53.2M Commerce Space Weather IT (MEDIUM)▲
L3Harris Technologies, Inc. holds $53,246,425 (potential $54.8M) non-competed cost-plus-fixed-fee from NOAA (Commerce) for space weather ground segment C2 through 2026 ($22M outlayed).
- Perini Management Services Inc. (Tutor Perini) Bags $42.3M Interior Utilities (MEDIUM)▲
Perini Management Services, Inc. (Tutor Perini subsidiary) awarded $42,272,441 firm-fixed-price from National Park Service (Interior) for wastewater utilities replacement via full/open competition.
Risk Flags (2)
- Execution [HIGH RISK]▼
High fixed-price execution risk on Johnson Controls Government Systems LLC's $75.7M DOE Oak Ridge ESPC ($0 outlayed, potential $251M options over 25 years to 2033) and Whiting-Turner Contracting Company's $74.5M DHS Coast Guard build ($0 outlayed to 2026).
- Budget [MEDIUM RISK]▼
Low outlays on recent awards like S.J. Amoroso's $69.5M VA ($0 outlayed) and R.E.D. Construction Services LLC's $39.8M VA hospital upgrades ($0 outlayed) signal potential budget delays amid CR risks for Oct-Dec awards.
Opportunities (3)
- ◆
Emergent BioDefense Operations Lansing LLC's $211.4M HHS BARDA biotech R&D has $436M unexercised options to $647.5M ceiling through potential 2032.
- ◆
Booz Allen Hamilton Inc. shows repeat civilian IT strength with $244.96M Interior + $40.1M DOE CYSOC ($30.9M outlayed), potential follow-ons post-2026.
- ◆
MicroHealth LLC's $36M VA IT set-aside (SDVOSB, potential $155M to 2029) and R.E.D. Construction's $39.8M VA SDVOSB hospital build signal policy-driven small business growth.
Sector Themes (3)
- ◆
VA dominates with Dell's $1.59B tech, S.J. Amoroso's $69.5M boiler plant, and R.E.D. Construction's $39.8M hospital upgrades, totaling over $1.7B in construction/IT mods.
- ◆
HHS awards include Emergent's $211.4M BARDA smallpox R&D, Maximus' $71.2M CDC contact centers, and Noridian's $64.6M CMS Medicare processing, evidencing biodefense/health admin priorities.
- ◆
Interior (NW Construction $257M, Booz Allen $245M, Perini $42M) and DOE (Johnson Controls $75.7M, Silver Lake $45.6M) show $600M+ in facilities/utilities builds.
Watch List (4)
- 👁
{"entity"=>"Dell Federal Systems L.P.", "reason"=>"$1.59B VA obligation lacks revenue/pricing details; track for annual revenue est. and execution.", "trigger"=>"outlay progress, post-2022-03-29 modifications"}
- 👁
{"entity"=>"Emergent BioDefense Operations Lansing LLC", "reason"=>"$211.4M HHS with $436M options unexercised ($173.9M outlayed).", "trigger"=>"options exercise toward $647.5M by 2028-10-01"}
- 👁
{"entity"=>"Booz Allen Hamilton Inc.", "reason"=>"Repeat wins: $245M Interior IT ($112.8M outlayed) + $40.1M DOE CYSOC ($30.9M outlayed).", "trigger"=>"outlay beyond current levels, 2026 end-date follow-ons"}
- 👁
{"entity"=>"Johnson Controls Government Systems, LLC", "reason"=>"$75.7M DOE ESPC at $0 outlayed with high fixed-price risk over 25 years.", "trigger"=>"outlay initiation, options to $251M"}
Get daily alerts with 7 investment signals, 2 risk alerts, 3 opportunities and full AI analysis of all 29 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Significant Contract Modifications ($10M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals